Nystatin Suspension Dosing for Oropharyngeal Candidiasis
For adults and children with mild oropharyngeal candidiasis, use nystatin suspension (100,000 U/mL) at 4–6 mL four times daily for 7–14 days, with the suspension retained in the mouth as long as possible before swallowing 1.
Specific Dosing by Age Group
Infants
- Dose: 2 mL (200,000 units) four times daily 2
- Administration technique: Use dropper to place one-half of dose in each side of mouth; avoid feeding for 5–10 minutes 2
- Premature/low birth weight infants: 1 mL four times daily is effective 2
Children and Adults
- Dose: 4–6 mL (400,000–600,000 units) four times daily 2
- Administration: Place one-half of dose in each side of mouth 2
- Key instruction: Retain preparation in mouth as long as possible before swallowing 2
Duration
- Standard: 7–14 days 1
- Continue treatment for at least 48 hours after symptoms disappear and cultures confirm Candida eradication 2
Clinical Context and Positioning
Nystatin is recommended as an alternative for mild oropharyngeal candidiasis, but it is NOT first-line therapy. The 2016 IDSA guidelines position nystatin as an alternative option with a strong recommendation but only moderate-quality evidence 1.
First-Line vs. Alternative Therapy
For mild disease, clotrimazole troches (10 mg 5 times daily) or miconazole buccal tablets are preferred first-line options with high-quality evidence 1. Nystatin suspension or pastilles are listed as alternatives 1.
For moderate to severe oropharyngeal candidiasis, oral fluconazole 100–200 mg daily for 7–14 days is the clear first choice (strong recommendation; high-quality evidence) 1.
Important Clinical Considerations
Efficacy Limitations
Research demonstrates that nystatin is significantly less effective than fluconazole in immunocompromised patients:
- Clinical cure rates: 51–52% with nystatin vs. 87–91% with fluconazole 3, 4
- Mycological eradication: 6–11% with nystatin vs. 60–76% with fluconazole 3, 4
- Relapse rates are higher with nystatin 3
When to Use Nystatin
Nystatin remains appropriate for:
- Mild disease where topical therapy is sufficient
- Patients who cannot tolerate or afford systemic azoles
- Situations where systemic absorption should be avoided
- Denture-related candidiasis (combined with denture disinfection) 1
Common Pitfalls
- Inadequate contact time: Patients must retain the suspension in their mouth as long as possible—simply swallowing it immediately reduces efficacy 2
- Premature discontinuation: Continue for 48 hours after symptom resolution to prevent relapse 2
- Using nystatin for moderate-severe disease: This is inappropriate; systemic therapy with fluconazole is required 1
- Poor taste compliance: Gastrointestinal adverse effects and poor taste are the most common reasons for treatment failure 5
Esophageal Candidiasis
Nystatin is NOT appropriate for esophageal candidiasis—systemic antifungal therapy is always required 1. Use oral fluconazole 200–400 mg daily for 14–21 days 1.